Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease: a pilot study in ten patients

P Herve, M Flesch, JY Cahn, E Racadot… - …, 1985 - journals.lww.com
P Herve, M Flesch, JY Cahn, E Racadot, E Plouvier, B Lamy, A Rozenbaum, A Noir…
Transplantation, 1985journals.lww.com
Copyright () 1985 by The Williams & Wilkins Co. Page 1 0041-1337/85/3902 013850200/0
TRANSPLANTATION Copyright () 1985 by The Williams & Wilkins Co. Vol. 39, No. 2 Printed in
USA REMOVAL, OF MARROW T CELLS WITHI OKT3. OKT 11 MONOCLONAL, ANTIBODIES
AND COMPLEMENT TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE A PILOT
STUDY IN TEN PATIENTS P. HERVE," “ M. FLEsc," JY CAHN," E. RACADoT," E. PLoUvIER,“
B. LAMY," A. RozENBAUM," A. NoIR,“ R. LEcoNTE DEs FLoRIs," AND A. PETERs" Unité de …
Abstract
We studied the feasibility of T cell depletion of bone marrow for transplantation in preventing acute graftversus-host disease GVHD in patients having a high risk of acute GVHD.
Lippincott Williams & Wilkins